Skip to main content
Equibles

ROSSARI · Rossari Biotech Limited · Financials

Use ROSSARI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ROSSARI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
436.00 INR +6.10 (+1.42%) At close · Nov 13
Rebalance outlook locked
Market Cap
24.15B INR
Shares
55.39M
Volume · Nov 13 79.56K Avg daily vol (3M) 76.87K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
23.96B +15.2%
FY2026 Revenue FY2021–FY2026
Net Income
1.49B +9.4%
FY2026 Net Income FY2021–FY2026
Operating Cash Flow
650.68M -52.7%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021
INR 26.61B 23.96B 20.8B 18.31B 16.56B 14.83B 7.09B
INR 988.53M 791.24M 670.73M 603.9M 629.31M 480.55M 228.29M
INR 363.78M 285.43M 178.11M 193.72M 223.15M 126.56M 29.92M
INR 509.42M 533.02M 488.07M 469.26M 369.62M 385.8M 267.92M
INR 1.53B 1.49B 1.36B 1.31B 1.07B 976.74M 802.2M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 137.97M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.